Febuxostat, a Xanthine-Oxidase-Inhibitor, Suppresses the Structural Remodeling in Atrium through Anti-Oxidative Effect in the Canine Model of Atrial Fibrillation.
日本循環器学会学術集会
Japanese Circulation Society
Osaka, Japan